Switch to:
Cryo-Cell International, Inc. (OTCPK:CCEL)
Cash from Financing
$-0.72 Mil (TTM As of Nov. 2013)

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Nov. 2013, Cryo-Cell International, Inc. paid $0.07 Mil more to buy back shares than it received from issuing new shares. It received $0.00 Mil from issuing more debt. It paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares. It received $0.00 Mil from paying cash dividends to shareholders. It received $0.00 Mil on other financial activities. In all, Cryo-Cell International, Inc. spent $0.07 Mil on financial activities for the three months ended in Nov. 2013.


Definition

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Cryo-Cell International, Inc.'s Cash from Financing for the fiscal year that ended in Nov. 2013 is calculated as:

Cash from Financing(A: Nov. 2013 )
=Net Issuance of Stock+Net Issuance of Debt+Net Issuance of Preferred+Dividends+Other Financing
=-0.739+0+0+0+0.015
=-0.72

Cryo-Cell International, Inc.'s Cash from Financing for the quarter that ended in Nov. 2013 is

Cryo-Cell International, Inc. Cash Flow from Financing for the trailing twelve months (TTM) ended in Nov. 2013 was -0.247 (Feb. 2013 ) + -0.409 (May. 2013 ) + -0.001 (Aug. 2013 ) + -0.067 (Nov. 2013 ) = $-0.72 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

Cash from financing contains five items:

1. Net Issuance of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. If this number is positive, it means that the company has received more cash from issuing shares than it has paid to buy back shares. If this number is negative, it means that company has paid more cash to buy back shares than it has received for issuing shares.

Cryo-Cell International, Inc.'s net issuance of stock for the three months ended in Nov. 2013 was $-0.07 Mil. Cryo-Cell International, Inc. paid $0.07 Mil more to buy back shares than it received from issuing new shares.

2. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Cryo-Cell International, Inc.'s net issuance of debt for the three months ended in Nov. 2013 was $0.00 Mil. Cryo-Cell International, Inc. received $0.00 Mil from issuing more debt.

3. Net Issuance of Preferred:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Cryo-Cell International, Inc.'s net issuance of preferred for the three months ended in Nov. 2013 was $0.00 Mil. Cryo-Cell International, Inc. paid $0.00 Mil more to buy back preferred shares than it received from issuing preferred shares.

4. Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cryo-Cell International, Inc.'s cash flow for dividends for the three months ended in Nov. 2013 was $0.00 Mil. Cryo-Cell International, Inc. received $0.00 Mil from paying cash dividends to shareholders.

5. Other Financing:
Money spent or earned by company from other financial activities.

Cryo-Cell International, Inc.'s other financing for the three months ended in Nov. 2013 was $0.00 Mil. Cryo-Cell International, Inc. received $0.00 Mil on other financial activities.


Related Terms

Cash Flow from Operations, Cash Flow from Investing, Net Issuance of Stock, Net Issuance of Debt, Dividends, Net Issuance of Preferred


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Cryo-Cell International, Inc. Annual Data

Nov04Nov05Nov06Nov07Nov08Nov09Nov10Nov11Nov12Nov13
Net Issuance of Stock 0.030.200.000.030.000.000.000.08-1.70-0.74
Net Issuance of Debt -0.150.000.000.000.000.000.000.000.000.00
Net Issuance of Preferred 0.000.000.000.000.000.000.000.000.000.00
Dividends 0.000.000.000.000.000.000.000.000.000.00
Other Financing 0.01-0.090.000.000.000.000.000.00-3.250.02
Cash from Financing -0.110.110.000.030.000.000.000.08-4.95-0.72

Cryo-Cell International, Inc. Quarterly Data

Aug11Nov11Feb12May12Aug12Nov12Feb13May13Aug13Nov13
Net Issuance of Stock 0.020.06-0.75-0.65-0.07-0.23-0.25-0.42-0.00-0.07
Net Issuance of Debt 0.000.000.000.000.000.000.000.000.000.00
Net Issuance of Preferred 0.000.000.000.000.000.000.000.000.000.00
Dividends 0.000.000.000.000.000.000.000.000.000.00
Other Financing -0.010.00-2.30-0.28-0.48-0.190.000.010.000.00
Cash from Financing 0.020.06-3.05-0.92-0.55-0.43-0.25-0.41-0.00-0.07
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Hide